[go: up one dir, main page]

NZ201412A - Preparation of 4-aminobutyramide - Google Patents

Preparation of 4-aminobutyramide

Info

Publication number
NZ201412A
NZ201412A NZ201412A NZ20141282A NZ201412A NZ 201412 A NZ201412 A NZ 201412A NZ 201412 A NZ201412 A NZ 201412A NZ 20141282 A NZ20141282 A NZ 20141282A NZ 201412 A NZ201412 A NZ 201412A
Authority
NZ
New Zealand
Prior art keywords
azidobutyramide
process according
aminobutyramide
effected
hydrolysis
Prior art date
Application number
NZ201412A
Inventor
J Gosteli
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NZ201412A publication Critical patent/NZ201412A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/535Organo-phosphoranes
    • C07F9/5355Phosphoranes containing the structure P=N-

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

New Zealand Paient Spedficaiion for Paient Number £01412 201412 Complete Spocsflcction Fifad: c??.7.'?f^ Cless: CP.1&??# ?P?& 1 a. £9 NOV 198#.
« .C;i giiaic:siiiiiiiii( Pk*. ...
P, > r^*' /T» **"• T V;, 1*0" • ■ • * is NEW ZEALAND 17/ 3 53>0 THE PATENTS ACT 1953 PATENTS FORM NO. 5 COMPLETE SPECIFICATION "PROCESS FOR THE PREPARATION OF 4-AMINOBUTYRAMIDE" WE, SYNTHELABO, a French Body Corporate of 58, rue de la Glaciere, 7 5013 Paris, France, hereby declare the invention for which we pray that a patent may be granted to us and the method by which it is to be performed, to be particularly described in and by the following statement: i- 7; -> .u.,. j.A 2 014 12 - DESCRIPTION "PROCESS FOR THE The present invention relates to a process for the preparation of 4-aminobutyramide of the formula: h2nch2ch2ch2conh2 (i) and acid addition salts thereof. This 4-aminobutyric acid 5 derivative is of great value because of its psychotropic properties (cf. V.M. Kopelevich* Usp. Khim. 48» 1273 [1979]).
The known synthesis of 4-aminobutyramide« according to which succinic acid dinitrile is used as the starting 10 material* is not suited to the requirements of manufacture, because of the poor yields (C. Berther# Chem. Ber. 92, 2616 [l959]). The recently published method for the preparation of 4-aminobutyramide involves the use of free hydrocyanic acid* which is highly toxic# and hydrogenation 15 under pressure# that is to say a series of reactions requiring safety measures and particular apparatuses (A. Kleeman et al_. , Angew. Chem. 9^« 640 [1980]).
According to the present invention, in an advantageous manner, 4-aminobutyramide is prepared by the 20 reduction of 4-azidobutyramide of the formula: n3ch2ch2ch2conh2 (ii) 201412 The reduction can be effected by means of hydrogen in the presence of a hydrogenation catalyst (e.g. palladium), and when that method is used it can be carried out without the application of pressure and at ambient temperature optionally in the presence of an acid (e.g. hydrogen chloride), resulting in the formation of an acid addition salt of 4-aminobutyramide. However, it is also possible to use other reducing agents. Thus, for example, it is possible first to react 4-azidobutyramide with a phosphine, such as a'trialkylphosphine or triphenyl-phosphine, and then to hydrolyse the intermediate imino-phosphine which has formed and which corresponds to the formula: r3p=n-ch2ch2ch2conh2 (hi) wherein R represents an alkyl radical, preferably containing at most 4 carbon atoms, or the phenyl radical. 4-Azidobutyramide, which is not described in the literature, can be prepared in a simple manner starting from the 4-azidobutyronitrile/ which is a known compound, by partial hydrolysis in an acid or basic medium. A particularly advantageous method of hydrolysis consists in carrying out the reaction in a basic medium with the addition of hydrogen peroxide. 2014 12 The following Examples illustrate the invention.
EXAMPLE 1 A solution of 1.53 g (12 millimols) of 4-azidobutyramide in 20 ml of absolute ethanol and 3.32 ml 5 of ethyl acetate, containing 12 milliinols of hydrogen chloride, is hydrogenated for 4 hours at ambient pressure and temperature in the presence of 1.53 g of palladium (5 %) on a barium sulphate support.
After filtration and evaporation of the filtrate 10 in vacuo, 1.13 g of a crystalline residue are collected; by extraction of the catalyst with hot methanol and evaporation in vacuo, a second fraction of 0.45 g of the crude crystalline hydrochloride of 4-aminobutyramide is obtained. Yield of crude product: 95 %. 15 At the expense of a loss of product, the crude product can be recrystallised from absolute alcohol. The pure product melts at 136-137°C.
EXAMPLE 2 3.62 g (10 millimols) of 4-triphenylphosphinimino-20 butyramide (formula III, R representing the phenyl radical) are dissolved in 17 ml of hot 95% alcohol.
After cooling to ambient temperature, 17 ml of concentrated ammonia solution (2 5%) are added and the clear solution is stirred for 24 hours. The major part of the alcohol is 25 evaporated off in vacuo, which causes triphenylphosphine oxide to precipitate. The residue is dissociated with a ? 0 1 4 1 2 mixture of water and methylene chloride# and the aqueous phase is cautiously concentrated in a rotary evaporator* which gives 1.20 g of a clear colourless oil: this crystallises in the cold. The crude product is triturated with diethyl ether* filtered off# washed with diethyl ether and dried. This gives 1.00 g of 4-aminobutyramide» which melts at 56-58°C. Yield 98 %.
EXAMPLE 3 22.8 g of triphenylphosphine are added to a solution of 11.1 g (87 millimols) of 4-azidobutyramide in 100 ml of toluene# at 60°C« the triphenylphosphine being added in small doses so as not to cause the temperature to rise above 70°C. Cooling of the mixture causes the 4-triphenylphosphiniminobutyramide (formula III# R representing the phenyl radical) to crystallise. By filtration# washing with cold toluene and drying in vacuo# 27.0 g of colourless crystals are collected# which corresponds to a yield 86% of theory. The melting point of the crystals is 124-128°C. After recrystallisation from ethyl acetate# the product#viz. triphenylphosphinimo-butyramide# melts at 128-132°C.
C22H23N2OP (362*4) % C calculated: 72.91 found: 72.66 % H 6.40 6.41 % N 7.73 7.83 014 12 - 5 -EXAMPLE 4 9.0 g (82 millimols) of 4-azidobutyronitrile and 20 ml of concentrated hydrochloric acid are stirred at ambient temperature; after a certain time, a single phase 5 is formed. After seven hours, the mixture is concentrated in vacuo and the 19 g of residual oil are diluted with 30 ml of water. The pH is adjusted to 8 by cautiously adding solid sodium carbonate, the solution is extracted four times with methylene chloride and the extracts are 10 dried over sodium sulphate. By evaporation in vacuo, 7.0 g of crude 4-azidobutyramide are obtained.
Yield: 66 %. After recrystallisation from diethyl ether, the 4-azidobutyramide melts at 73-73.5°C.
C4H8N4° % C calculated: 37.49 found: 37.66 % H 6.29 6.33 % N 43.73 43.62 EXAMPLE 5 46 ml of a 30 % solution of hydrogen peroxide 20 are added to a solution of 23.3 g of 4-azidobutyronitrile in 70 ml of alcohol. 17 ml of normal sodium hydroxide solution are introduced, with stirring, care being taken not to exceed a temperature of 37°C. After this addition, the mixture is stirred for a further two hours, 25 the alcohol is driven off by distillation in a vacuum evaporator, the residue is diluted with a small amount of 2014 12 water and extraction is carried out twice with pentane. The extract is discarded and the aqueous phase is saturated with sodium chloride and shaken six times with ethyl acetate. The extracts are combined, washed with a solution of sodium chloride, dried over sodium sulphate and concentrated in a rotary evaporator. The crystalline residue is suspended in diethyl ether, the suspension is brought briefly to the boil and, after cooling, the product is filtered off. After drying in vacuo, 17.7 g of crystals of 4-azidobutyramide, melting at 73-73. 5°C, are collected. By concentration of the mother liquor, a second fraction of 5.3 g of crystals of 4-azidobutyramide, melting at 70.5-71.5°Ct is obtained. Yield: 85 %. 9> 0 J £ -i o

Claims (7)

WHAT WE CLAIM IS:
1. Process for the preparation of 4-aminobutyramide and acid addition salts thereof characterised in that 4-azidobutyramide is reduced.
2. Process according to claim 1 characterised 5 in that the reduction of 4-azidobutyramide is effected by means of hydrogen in the presence of a hydrogenation catalyst.
3. Process according to claim 1 or 2 characterised in that the reduction of 4-azidobutyramide 10 is carried out' at ambient temperature and under normal pressure.
4. Process according to claim 1 characterised in that 4-azidobutyramide is first reacted with a trialkyl-phosphine or a triphenylphosphine* and the iminophosphine 15 thus obtained is then hydrolysed.
5. Process according to claim 1 characterised in that the 4-azidobutyramide is prepared by the partial hydrolysis of 4-azidobutyronitrile.
6. Process according to claim 5 characterised 20 in that the hydrolysis is effected by means of an aqueous acid.
7. Process according to claim 5 characterised in that the hydrolysis is effected in an aqueous medium by adding hydrogen peroxide. ByiWsr/Their Authorised Agents. A. J. PARK & snw ! A. J. PARK & SON
NZ201412A 1981-07-29 1982-07-28 Preparation of 4-aminobutyramide NZ201412A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8114695A FR2510560A1 (en) 1981-07-29 1981-07-29 PROCESS FOR THE PREPARATION OF 4-AMINO BUTYRAMIDE

Publications (1)

Publication Number Publication Date
NZ201412A true NZ201412A (en) 1984-11-09

Family

ID=9260950

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ201412A NZ201412A (en) 1981-07-29 1982-07-28 Preparation of 4-aminobutyramide

Country Status (16)

Country Link
EP (1) EP0071500B1 (en)
JP (1) JPS5826846A (en)
AR (1) AR230045A1 (en)
AT (1) ATE13421T1 (en)
AU (1) AU8652282A (en)
DE (1) DE3263745D1 (en)
DK (1) DK337182A (en)
ES (1) ES514464A0 (en)
FI (1) FI822647L (en)
FR (1) FR2510560A1 (en)
GR (1) GR77232B (en)
IL (1) IL66419A0 (en)
NO (1) NO822264L (en)
NZ (1) NZ201412A (en)
PT (1) PT75340B (en)
ZA (1) ZA825432B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855455A (en) * 1988-01-22 1989-08-08 W. R. Grace & Co.-Conn. Preparation of amino acid derivatives
DE60142470D1 (en) 2000-04-24 2010-08-12 Vertex Pharma METHOD AND INTERMEDIATE PRODUCTS FOR THE PREPARATION OF SUBSTITUTED ASPARAGINIC ACETALES
DE102009024113A1 (en) 2009-06-06 2010-12-09 Matthias Bahlmann Preparing 4-azidobutyric acid amide, useful as an intermediate for producing 4-aminobutyric acid and progabide drug, comprises reacting 4-halobutyric acid amide with an alkali azide in the presence of a phase transfer catalyst
JP6350910B2 (en) * 2014-07-04 2018-07-04 富士フイルム和光純薬株式会社 Method for producing azidoamine derivative
CN117105803B (en) * 2023-08-25 2025-08-12 国药集团化学试剂有限公司 A preparation method of gamma-aminobutyramide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3880922A (en) * 1972-02-03 1975-04-29 Merck & Co Inc Process for preparing 3-fluoro-D-alanine by asymmetric rearrangement of 2-(azidocarbonyl)-3-fluoro-propionic ester or nitrile
DE2506110C2 (en) * 1975-02-13 1983-04-21 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Process for the preparation of 2-amino-N - (β-hydroxy-2,5-dimethoxy-phenethyl) -acetamide (midodrin)

Also Published As

Publication number Publication date
NO822264L (en) 1983-01-31
IL66419A0 (en) 1982-11-30
FI822647A0 (en) 1982-07-28
EP0071500A1 (en) 1983-02-09
JPS5826846A (en) 1983-02-17
ES8305686A1 (en) 1983-04-16
AU8652282A (en) 1983-02-03
GR77232B (en) 1984-09-11
PT75340A (en) 1982-08-01
FR2510560B1 (en) 1983-12-09
EP0071500B1 (en) 1985-05-22
DE3263745D1 (en) 1985-06-27
FI822647A7 (en) 1983-01-30
ATE13421T1 (en) 1985-06-15
AR230045A1 (en) 1984-02-29
ZA825432B (en) 1983-06-29
DK337182A (en) 1983-01-30
PT75340B (en) 1985-11-29
FI822647L (en) 1983-01-30
ES514464A0 (en) 1983-04-16
FR2510560A1 (en) 1983-02-04

Similar Documents

Publication Publication Date Title
US5107032A (en) Process for the preparation of o-phthalaldehydes
DE2256055C2 (en) Process for the preparation of dipeptide-lower-alkyl esters which contain the α-L-asparagyl radical and which can be used as a sweetener
US3733352A (en) Preparation of d-threo-1-p-methyl-sulfonylphenyl-2-dichloro-acet-amidopropane-1,3-diol
EP0208948B1 (en) A method for optical resolution of phenylacetic acid derivative
SU648082A3 (en) Metho of obtaining amino acid deriva]ves, their salts, racemates or optically active antipodes
NZ201412A (en) Preparation of 4-aminobutyramide
CN114621103B (en) Preparation method of salbutamol sulfate
SU843749A3 (en) Method of preparing 4a,9b-trans-hexahydro-gamma-carboline
US5306833A (en) Preparation process for arylacetic acids and their alkali metal salts
EP0257920B1 (en) Process for l-dopa
US6570022B2 (en) Preparation of bis-(1(2)H-tetrazol-5-yl)-amine monohydrate
IE49709B1 (en) Pyrimidine derivatives
US4668798A (en) Process for preparing pyrrolidine derivatives
US4925942A (en) Preparation of quinuclidine-3-methanol
CA1125762A (en) Dihydronicotinic acid derivatives and process for the preparation thereof
DE2034682A1 (en) Production of ice 1 propenylphosphonic acid
HU186528B (en) Process for producing tetronnoic acid
EP0479960B1 (en) Method for the synthesis of trisodium phosphonoformate hexahydrate
CN115611739B (en) Preparation method of benpropenoic acid intermediate and intermediate thereof
SU406355A1 (en)
US4960923A (en) Pure crystalline methyl 2-acryloylamino-2-methoxy acetate and a process for preparing IT
US2517496A (en) Preparation of symmetrical monoaminodihydroxytoluene
SU172739A1 (en) Method for producing 2,4-dinitrophenylalkyl esters
US4308383A (en) N-(3-(1'-3"-Oxapentamethyleneamino-ethylideneamino)-2,4,6-triiodobenzoyl)-β-amino-α-methylpropionitrile
DE2023461C3 (en) Process for the production of L- and DL-Dopa and their derivatives